The perfect audience for Phexxi is “the ladies who are using condoms, relying on the pullout method and hoping for the finest, or the females using a natural family-planning method,” stated Erin Turner, a brand manager at Evofem– the business that produces Phexxi.Although the New York Times description of the Evofem offices sounds like a girlboss version of hell (a hot pink Joan of Arc and a cup with the phrase “Tears of My Enemies” are included), Phexxi as an item definitely appears to have its advantages. With normal usage, Phexxi is about 86% efficient, which is in the same range as other contraceptive options– condoms have an 87% typical-use effectiveness rate, while diaphragms have a rate of 83%, and the tablet is efficient 93% of the time.Since Phexxi went on sale last September, Evofem has actually apparently provided roughly 17,280 prescriptions. Evofem is also presently doing screening on the Phexxi solution as a prevention method for the STIs chlamydia and gonorrhea, a status which requires FDA approval, however could possibly increase the products audience.The language used by Evofem CEO Saundra Pelletier and other Evofem employees suggests that part of the thinking behind the development of Phexxi is the recent popularity of a “health” related hostility to hormonal approaches of control.
- Coronavirus in Oregon: 370 new cases, 10 deaths – OregonLive
- 2,143 test positive for HIV – GhanaWeb